CHICAGO, July 29, 2011 /PRNewswire/ — The Female Health Company
(Nasdaq:
FHCO) today announced that it will host an investor conference
call to discuss its operating results for the third quarter and
first nine months of FY2011 on Friday, August 5, 2011 at 11:00 a.m.
Eastern Time (EDT). The Company expects to report its
operating results earlier the same day.
Shareholders and other interested parties may participate in
the conference call by dialing 1-877-374-8416 (international
participants dial 1-412-317-6716) and asking to be connected to
“The Female Health Company Conference Call” a few minutes before
11:00 a.m. EDT on August 5, 2011. A replay of the call will
be available one hour after the call through 9:00 a.m. EDT on
Monday, August 22, 2011 by dialing 877-344-7529
(international callers dial 412-317-0088) and entering
the conference ID 10002775.
About The Female Health
Company
The Female Health Company, based in Chicago, Illinois,
manufactures and markets the FC2 Female Condom® (FC2),
which is available in the U.S. and about 120 other countries
globally. The Company owns certain worldwide rights to the
FC2 Female Condom®, including patents that have been
issued in the U.S., Europe, Canada, Australia, South Africa, Japan,
Spain, Greece, Turkey and the People’s Republic of China, and
pending in various countries. The FC2 Female
Condom® is the only available FDA-approved product
controlled by a woman that offers dual protection against sexually
transmitted diseases, including HIV/AIDS, and unintended pregnancy.
The World Health Organization (WHO) has cleared FC2
for purchase by U.N. agencies.
“Safe Harbor” statement under the Private Securities
Litigation Reform Act of 1995:
Th
‘/>”/>
